Kezdőlap › Nem kis sejtes tüdőrák › Észak-Karolina › Durham
Nem kis sejtes tüdőrák klinikai vizsgálatok: Durham, NC
39 Nem kis sejtes tüdőrák vizsgálat keres résztvevőket Durham és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Toborzás folyamatban2. fázis
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- Duke University, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Toborzás folyamatban1. fázis
- Exelixis Clinical Site #12, Durham
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Toborzás folyamatban3. fázis
- UNC Lineberger Comprehensive Cancer Center ( Site 3250), Chapel Hill · 10 mérföldre
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Toborzás folyamatban3. fázis
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Toborzás folyamatban3. fázis
- Duke Cancer Center, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Toborzás folyamatban1. fázis
- PHN-012-001 Site, Durham
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Toborzás folyamatban3. fázis
- UNC Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mérföldre
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Toborzás folyamatban3. fázis
- Duke University Medical Center, Durham
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Toborzás folyamatban2. fázis
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mérföldre
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Toborzás folyamatban1/2. fázis
- Duke Cancer Center Durham, Durham
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Toborzás folyamatban3. fázis
- Clinical Study Site, Durham
- Clinical Study Site, Chapel Hill · 10 mérföldre
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Toborzás folyamatban3. fázis
- Durham VA Health Care System, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Toborzás folyamatban1/2. fázis
- Duke University School of Medicine, Durham
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Toborzás folyamatban2/3. fázis
- Duke University Medical Center, Durham
Effects of Infusion Timing on Treatment Response in Solid Tumors
Toborzás folyamatban2. fázis
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mérföldre
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Toborzás folyamatbanMegfigyeléses tanulmány
- UNC- Chapel Hill, Chapel Hill · 10 mérföldre
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Toborzás folyamatban1. fázis
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Toborzás folyamatban3. fázis
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mérföldre
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Toborzás folyamatban1. fázis
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 mérföldre
- University of North Carolina, Chapel Hill · 10 mérföldre
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Toborzás folyamatban1/2. fázis
- Duke Cancer Institute, Durham
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Toborzás folyamatban2. fázis
- UNC Health - University of North Carolina, Chapel Hill · 10 mérföldre
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Toborzás folyamatban1. fázis
- Duke University Medical Center, Durham
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Toborzás folyamatban1/2. fázis
- Duke Cancer Institute, Durham
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Duke Cancer Center, Durham
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Toborzás folyamatban2. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Toborzás folyamatban1. fázis
- Duke Cancer Institute /ID# 276267, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Toborzás folyamatban1. fázis
- Research Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Toborzás folyamatban1. fázis
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Toborzás folyamatban1. fázis
- Duke Cancer Center /ID# 251975, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Toborzás folyamatban2. fázis
- Durham VA Medical Center, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Toborzás folyamatban1. fázis
- Duke Cancer Center, Durham
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Toborzás folyamatban2/3. fázis
- Durham VA Medical Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Toborzás folyamatban
- Durham VA Medical Center, Durham, NC, Durham
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Toborzás folyamatbanKorai 1. fázis
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mérföldre
GEMINI-NSCLC: NSCLC Biomarker Study
Toborzás folyamatbanMegfigyeléses tanulmány
- Duke University, Durham
- UNC, Chapel Hill · 10 mérföldre
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mérföldre
A Study of NX-1607 in Adults With Advanced Malignancies
Toborzás folyamatban1. fázis
- University of North Carolina, Chapel Hill · 10 mérföldre
Nem kis sejtes tüdőrák vizsgálatok más városokban
- Houston, TX145 tanulmány
- New York City, NY121 tanulmány
- Arlington, VA104 tanulmány
- Nashville, TN97 tanulmány
- Boston, MA90 tanulmány
- Los Angeles, CA87 tanulmány
- St. Louis, MO73 tanulmány
- Chicago, IL61 tanulmány
- Baltimore, MD60 tanulmány
- San Antonio, TX59 tanulmány
- Columbus, OH57 tanulmány
- Washington, DC55 tanulmány
Egyéb vizsgálatok: Durham
- Mellrák64 tanulmány
- Rák (minden típus)58 tanulmány
- Multiplex mielóma37 tanulmány
- Akut mieloid leukémia33 tanulmány
- Áttétes rák33 tanulmány
- Prosztatarák32 tanulmány
- Tüdőrák32 tanulmány
- Kolorektális rák28 tanulmány
- Petefészekrák27 tanulmány
- Krónikus limfocitás leukémia27 tanulmány
- Szívelégtelenség26 tanulmány
- Hasnyálmirigyrák24 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.